This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A New Era

Scott M. Grundy, MD, PhD

JAMA. 1986;256(20):2849-2858.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SEVERAL important developments have recently given new impetus to prevention of coronary heart disease (CHD) through control of the plasma cholesterol level. Three advances have been particularly dramatic. First, the Nobel prize in medicine was awarded in 1985 to Drs Joseph Goldstein and Michael Brown for their discovery of cell-surface receptors for low-density lipoproteins (LDLs); their finding was fundamental to our understanding of how plasma cholesterol levels are controlled. Second, the Lipid Research Clinics (LRC) Coronary Primary Prevention Trial (CPPT)¹ reported that lowering of the plasma cholesterol level by bile acid sequestrants reduces the frequency of several manifestations of CHD, including myocardial infarction. And third, a new class of cholesterollowering drugs, namely, competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis, has been shown to markedly lower cholesterol levels.^2-4 Although these inhibitors are not yet approved for clinical use, they reveal the potential for . . . [Full Text PDF of this Article]

Author Affiliations
From the Center for Human Nutrition and the Departments of Clinical Nutrition, Internal Medicine, and Biochemistry, University of Texas Health Science Center at Dallas.

Footnotes
Reprint requests to Room Y3-206, University of Texas Health Science Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9052 (Dr Grundy).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?